Virtu Financial LLC Buys Shares of 14,939 Align Technology, Inc. (NASDAQ:ALGN)

Virtu Financial LLC bought a new stake in Align Technology, Inc. (NASDAQ:ALGN) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 14,939 shares of the medical equipment provider’s stock, valued at approximately $3,115,000.

Several other institutional investors also recently bought and sold shares of ALGN. Natixis Advisors LLC boosted its stake in Align Technology by 21.8% in the third quarter. Natixis Advisors LLC now owns 18,654 shares of the medical equipment provider’s stock valued at $4,744,000 after acquiring an additional 3,344 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Align Technology in the third quarter valued at approximately $742,000. Prospera Private Wealth LLC purchased a new position in shares of Align Technology in the third quarter worth $114,000. Commerce Bank raised its holdings in shares of Align Technology by 47.0% in the third quarter. Commerce Bank now owns 3,381 shares of the medical equipment provider’s stock worth $860,000 after buying an additional 1,081 shares during the last quarter. Finally, First Horizon Advisors Inc. raised its holdings in shares of Align Technology by 16.2% in the third quarter. First Horizon Advisors Inc. now owns 990 shares of the medical equipment provider’s stock worth $252,000 after buying an additional 138 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.

Align Technology Stock Performance

ALGN stock opened at $168.61 on Friday. The firm has a market cap of $12.41 billion, a PE ratio of 30.06, a P/E/G ratio of 2.24 and a beta of 1.69. The firm’s fifty day moving average is $198.78 and its 200 day moving average is $216.64. Align Technology, Inc. has a one year low of $158.13 and a one year high of $331.64.

Align Technology (NASDAQ:ALGN) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.43 by ($0.47). Align Technology had a net margin of 10.54% and a return on equity of 13.84%. Research analysts predict that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have issued reports on ALGN. Evercore ISI raised their price target on shares of Align Technology from $240.00 to $260.00 and gave the stock an “outperform” rating in a report on Thursday, February 6th. Wells Fargo & Company began coverage on shares of Align Technology in a report on Friday, February 14th. They issued an “overweight” rating and a $255.00 price target for the company. Bank of America raised their price target on shares of Align Technology from $200.00 to $206.00 and gave the stock an “underperform” rating in a report on Friday, December 13th. Morgan Stanley decreased their price target on shares of Align Technology from $280.00 to $272.00 and set an “overweight” rating for the company in a report on Thursday, February 6th. Finally, Leerink Partnrs raised shares of Align Technology from a “hold” rating to a “strong-buy” rating in a report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $266.73.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.